Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
IMNM on Nasdaq
Shares outstanding
109,968,942
Price per share
$25.07
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
118,320,128
Total reported value
$2,540,565,633
% of total 13F portfolios
0%
Share change
+26,999,444
Value change
+$630,562,044
Number of holders
181
Price from insider filings
$25.07
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +113% $152,894,064 +$80,670,694 13,056,709 +112% FMR LLC 30 Sep 2025
T. Rowe Price Investment Management, Inc. 12% $124,649,133 10,644,674 T. Rowe Price Investment Management, Inc. 31 Oct 2025
Redmile Group, LLC 5.2% -17% $122,830,910 +$7,672,613 5,718,385 +6.7% Redmile Group, LLC 31 Dec 2025
Point72 Asset Management, L.P. 5.9% $41,638,177 4,887,110 Point72 Asset Management, L.P. 31 Jan 2025
Enavate Sciences GP, LLC 4.3% $73,483,864 4,768,583 Enavate Sciences GP, LLC 18 Dec 2025
Immunome Aggregator, LP 6% $40,628,327 4,768,583 Immunome Aggregator, LP 31 Jan 2025
VANGUARD GROUP INC 5.2% +7.8% $42,082,054 +$14,150,080 4,524,952 +51% The Vanguard Group 30 Jun 2025
EcoR1 Capital, LLC 4.7% $34,756,616 4,079,415 EcoR1 Capital, LLC 31 Mar 2025
JANUS HENDERSON GROUP PLC 2.2% -55% $16,313,738 -$13,130,862 1,914,758 -45% JANUS HENDERSON GROUP PLC 31 Mar 2025

As of 31 Dec 2025, 181 institutional investors reported holding 118,320,128 shares of Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM). This represents 108% of the company’s total 109,968,942 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM) together control 92% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 15% 16,549,716 +27% 0.02% $355,487,900
T. Rowe Price Investment Management, Inc. 12% 13,421,987 +59% 0.18% $288,305,000
BlackRock, Inc. 6.9% 7,594,996 +30% 0% $163,140,515
Point72 Asset Management, L.P. 6.4% 7,034,952 +46% 0.24% $151,110,769
VANGUARD GROUP INC 5.5% 6,038,414 +23% 0% $129,705,133
Redmile Group, LLC 5.2% 5,718,385 +14% 9% $122,830,910
ENAVATE SCIENCES GP, LLC 4.3% 4,768,583 0% 20% $102,429,163
PRIMECAP MANAGEMENT CO/CA/ 4.3% 4,685,441 +55% 0.08% $100,643,273
STATE STREET CORP 3.5% 3,868,000 +38% 0% $83,084,640
Driehaus Capital Management LLC 3.4% 3,705,974 +432% 0.54% $79,604,322
PRICE T ROWE ASSOCIATES INC /MD/ 3.1% 3,380,240 -9.7% 0.01% $72,608,000
JPMORGAN CHASE & CO 2.6% 2,855,747 +8659% 0% $61,341,446
EcoR1 Capital, LLC 2.6% 2,855,590 -30% 2.8% $61,338,073
GEODE CAPITAL MANAGEMENT, LLC 2.1% 2,361,381 +25% 0% $50,731,482
Jefferies Financial Group Inc. 1.8% 2,000,000 -4.8% 0.35% $42,960,000
READYSTATE ASSET MANAGEMENT LP 1.7% 1,843,210 +40% 1.8% $39,592,151
CITADEL ADVISORS LLC 1.6% 1,740,705 +107% 0.03% $37,390,343
MORGAN STANLEY 1.6% 1,709,089 -6.8% 0% $36,711,252
Sofinnova Investments, Inc. 1.5% 1,618,477 +271% 1.5% $34,764,886
Woodline Partners LP 1.4% 1,575,398 +24% 0.13% $33,839,549
Balyasny Asset Management L.P. 1.3% 1,429,680 0.06% $30,709,526
PRINCIPAL FINANCIAL GROUP INC 1.3% 1,404,450 +27% 0.02% $30,167,586
SILVERARC CAPITAL MANAGEMENT, LLC 1% 1,126,210 3.5% $24,190,991
WELLINGTON MANAGEMENT GROUP LLP 0.85% 934,463 +268% 0% $20,072,265
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.76% 840,689 +27% 0% $18,058,000

Institutional Holders of Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 118,320,128 $2,540,565,633 +$630,562,044 $21.48 181
2025 Q3 91,384,562 $1,070,118,014 +$140,282,314 $11.71 153
2025 Q2 79,431,966 $738,692,421 +$30,839,753 $9.30 142
2025 Q1 76,944,016 $518,447,649 +$156,654,047 $6.73 141
2024 Q4 53,313,664 $566,321,086 -$37,080,544 $10.62 119
2024 Q3 51,629,246 $754,701,793 +$58,776,153 $14.62 114
2024 Q2 47,779,242 $578,110,445 +$106,966,991 $12.10 112
2024 Q1 36,616,859 $903,617,775 +$377,900,927 $24.68 102
2023 Q4 21,490,560 $229,948,765 +$205,035,908 $10.70 57
2023 Q3 2,729,076 $22,706,803 +$3,521,335 $8.35 36
2023 Q2 1,949,082 $15,421,801 +$698,301 $7.91 35
2023 Q1 1,860,095 $9,343,739 -$1,198,225 $4.99 30
2022 Q4 2,100,648 $4,845,087 -$694,148 $2.21 28
2022 Q3 2,300,040 $10,208,297 -$14,594 $4.43 23
2022 Q2 2,313,613 $7,426,000 -$1,197,731 $3.21 24
2022 Q1 2,694,238 $15,433,000 -$858,955 $5.68 26
2021 Q4 2,790,928 $36,364,000 +$4,810,967 $12.96 28
2021 Q3 2,391,433 $58,321,000 +$6,054,335 $24.35 31
2021 Q2 2,376,109 $41,107,000 +$6,432,363 $17.30 25
2021 Q1 1,909,240 $64,673,000 +$1,324,022 $33.86 30
2020 Q4 2,013,500 $19,489,000 +$19,489,000 $9.68 24